Red Biotechnology Market Growth Accelerated by Expanded Application Areas

-

Red biotechnology refers to technology that involves biological and medical applications of biotechnology, including genetic engineering, gene therapy, immunotherapy, stem cell therapy and regenerative medicine. Red biotechnology products consist of tissue engineering and prosthetic implants, gene therapy, and therapeutic protein drugs and vaccines. These products help to diagnose, prevent and treat many diseases and enhance human health. The global Red Biotechnology Market is estimated to be valued at US$ 855.71 Bn in 2023 and is expected to exhibit a CAGR of 19% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.


Market key trends:
The expanding application areas of red biotechnology products is one of the major trends driving the growth of red biotechnology market. Red biotechnology finds increasing application in the development of diagnostic tools, therapeutic agents, and medical devices. With the advancements in genomics and proteomics, red biotechnology is playing a vital role in drug discovery and development process by identifying new drug targets. Moreover, increasing R&D investments by pharmaceutical and biotechnology companies to develop novel biologics such as cell and gene therapies have accelerated the market growth. These novel therapies hold promise for the treatment of cancer, genetic disorders, and infectious diseases.

Segment Analysis
The global red biotechnology market size is dominated by the pharmaceutical biotechnology segment. Pharmaceutical biotechnology is the largest and fastest growing sub-segment as it involves development and manufacturing of therapeutic proteins, monoclonal antibodies, stem cell therapy, regenerative medicine products, and gene therapy products which are used in treating diseases such as cancer, infectious diseases, genetic disorders, and others. The increasing demand for biologics and biotechnology-derived products for the treatment of various chronic and life-threatening diseases has been a major factor driving the growth of this sub-segment.

Key Takeaways
The global red biotechnology market is expected to witness high growth over the forecast period.

Regional analysis: North America is currently the dominant as well as the fastest growing regional market for red biotechnology. High healthcare expenditure, large pharmaceutical industry presence, availability of latest technologies, and high R&D investments are some of the major factors supporting the growth of the red biotechnology market in the region. The US contributes significantly to the growth of the North American market.

Key players operating in the red biotechnology market are Keir Surgical Ltd., Case Medical, Scanlan International, Inc., Koch Industries, Getinge Group, B. Braun (Aesculap, Inc.), Xerafy, Mobile Aspects, Key Surgical, Inc., Spatrack Medical Limited, Fortive Corporation Group, Haldor Advanced Technologies, Tgx Medical Systems, Becton, Dickinson and Company, Intechnology Distribution Pty Ltd., Nutrace, Steris Insturment Management Services, Material Management Microsystems, Asanus Medizintechnik GmbH Inc., and Stanley Healthcare (Division of Stanley Black & Decker), among others.

Comments

Post a Comment

Popular posts from this blog

The global Calcium Citrate Malate Market Growth Accelerated by Expanding Applications

-
Image
Calcium citrate malate is an essential mineral compound that provides calcium and supports bone health. Calcium citrate malate supplements help maintain healthy bones and teeth as we age. They support calcium absorption and distribution throughout the body. The global Calcium Citrate Malate Market is estimated to be valued at US$ 334.08 Mn in 2024 and is expected to exhibit a CAGR of 8.4% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The expanding applications of calcium citrate malate are expected to drive the market growth over the forecast period. Calcium citrate malate supplements are increasingly being used to prevent and treat osteoporosis. They are especially recommended for people who cannot digest lactose or avoid dairy products. The compound is also finding wider use in functional foods and beverages with added calcium and minerals. Manufacturers are developing various product formats like...
Read more

Labor Productivity Tracking Market Growth Accelerated by Remote Work and Digitalization Trend

-
Image
Labor productivity tracking solutions help businesses and organizations track employee productivity in real-time. These solutions offer features like time tracking, activity monitoring, goal setting, resource allocation, attendance logging, and analytics. They help enhance productivity by identifying opportunities for improvement, streamlining workflows, and ensuring employees are focused on tasks that add value. The global Labor Productivity Tracking Market is estimated to be valued at US$ 6.81 Billion in 2024 and is expected to exhibit a CAGR of 38% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The rapid adoption of remote work and digitalization trend across industries during the pandemic has been a major driver accelerating growth of the labor productivity tracking market. Many organizations have now accepted work from home and hybrid work models. Labor productivity tracking solutions help employers...
Read more

Myopia and Presbyopia Eye Drops Market Growth Accelerated by Increase In Myopia And Presbyopia Cases

-
Image
Myopia and Presbyopia eye drops are used for temporary relief from blurred vision caused by refractive errors such as nearsightedness and farsightedness. Myopia and presbyopia eye drops contain saline or other solutions which helps in moisturizing the eyes and providing temporary relief from vision issues. Increase in usage of digital devices and lack of outdoor activities have accelerated the cases of myopia and presbyopia worldwide. The global Myopia And Presbyopia Eye Drops Market is estimated to be valued at US$ 1.8 billion in 2023 and is expected to exhibit a CAGR of 8.2% over the forecast period 2023-2033, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing prevalence of myopia and presbyopia cases globally is the major key trend fueling the growth of the market. According to a study by The International Myopia Institute, it is estimated that around 50% of the world's population will suffer from myopia by the year 2050. T...
Read more